Digital Signatures vs Electronic Signatures: Key Differences

A digital signature is a specific type of electronic signature that uses public key infrastructure (PKI) cryptography to mathematically verify the signer's identity and detect document tampering. An electronic signature is the broader legal concept: any electronic indication of intent to sign a record, including typed names, click-to-accept buttons, drawn signatures, and digital signatures. All digital signatures are electronic signatures, but not all electronic signatures are digital signatures.

This guide explains the precise technical and legal differences between digital signatures and electronic signatures, when to use each, and what regulated organizations should know to make the right choice.

What Is the Difference Between a Digital Signature and an Electronic Signature?

What Is an Electronic Signature?

An electronic signature (e-signature) is a broad legal concept. It encompasses any electronic indication of intent to agree to or approve a document. Under the U.S. ESIGN Act, it's defined as "an electronic sound, symbol, or process, attached to or logically associated with a contract or other record and executed or adopted by a person with the intent to sign."

Electronic signatures include a wide spectrum of methods: typing your name, clicking a button, drawing with a stylus, voice authorization, and even biometric verification. The defining characteristic is intent, not the technology used. For a full overview, see our guide on what electronic signatures are.

What Is a Digital Signature?

A digital signature is a specific type of electronic signature that uses cryptographic techniques, specifically public key infrastructure (PKI), to provide mathematical proof of a document's authenticity and integrity. When someone applies a digital signature, the process generates a unique cryptographic hash of the document, encrypts that hash with the signer's private key, and embeds the result into or alongside the document.

Anyone with access to the signer's public key (contained in a digital certificate issued by a Certificate Authority) can verify two things: that the signature was created by the claimed signer, and that the document hasn't been modified since signing.

Technical Differences

The core distinction lies in how each type achieves trust. Understanding the underlying technology clarifies when each is appropriate.

How Digital Signatures Work (PKI)

Digital signatures rely on asymmetric cryptography, which uses a pair of mathematically related keys:

1. Private key: Held exclusively by the signer. Used to create the signature. Must never be shared.
2. Public key: Available to anyone who needs to verify the signature. Contained in a digital certificate issued by a trusted Certificate Authority (CA).

The signing process works as follows:

1. The document content is processed through a cryptographic hash function (e.g., SHA-256), producing a fixed-length hash value, a unique "fingerprint" of the document.
2. The hash is encrypted using the signer's private key, creating the digital signature.
3. The digital signature is attached to the document along with the signer's digital certificate.
4. The recipient uses the signer's public key (from the certificate) to decrypt the signature and recover the original hash.
5. The recipient independently hashes the document. If both hashes match, two facts are established: the signer is authentic, and the document is unmodified.

How Electronic Signatures Establish Trust

Non-digital electronic signatures rely on different mechanisms to establish trust and prove signing intent:

• Authentication: Identity verification through email validation, passwords, SMS codes, multi-factor authentication, or knowledge-based questions.
• Audit trails: Timestamped logs of every action: when the document was sent, viewed, and signed, from which IP address, and with what authentication method.
• Tamper detection: Platform-level mechanisms such as document hashing and sealed PDFs that reveal if a document has been modified after signing.
• Consent records: Explicit capture of the signer's intent through affirmative actions (checking boxes, clicking "Sign," drawing a signature).

The key difference: digital signatures provide cryptographic proof at the document level, while other electronic signatures rely on platform-level evidence collected during the signing process.

Side-by-Side Comparison

Legal Differences

Both electronic signatures and digital signatures are legally valid, but their legal treatment varies by jurisdiction.

United States

The ESIGN Act and UETA don't distinguish between electronic and digital signatures. Both are treated equally as long as four core requirements are met: intent to sign, consent to do business electronically, association of the signature with the record, and record retention. U.S. law is deliberately technology-neutral.

Specific regulations layer additional requirements on top of this baseline, though. FDA 21 CFR Part 11 doesn't mandate PKI-based digital signatures, but it does require unique user identification, two-factor authentication, audit trails, and system validation. Those controls go well beyond a simple e-signature.

European Union

The eIDAS Regulation creates an explicit hierarchy that maps closely to the digital vs. electronic distinction:

• Simple Electronic Signatures (SES): Legally admissible but carry the least evidentiary weight. No PKI required.
• Advanced Electronic Signatures (AES): Must be uniquely linked to the signatory, capable of identifying them, under their sole control, and linked to the data in a tamper-detectable way. Often implemented using digital signature technology.
• Qualified Electronic Signatures (QES): An AES created with a qualified certificate and a qualified signature creation device (QSCD). This is, by definition, a digital signature backed by a government-accredited trust provider. QES is the only type with automatic legal equivalence to a handwritten signature across all EU member states.

For a detailed comparison of U.S. and EU frameworks, read our article on eIDAS vs the ESIGN Act.

When Should You Use Digital Signatures vs Electronic Signatures?

When Electronic Signatures Are Sufficient

For most business transactions, a well-implemented electronic signature with a strong audit trail is entirely adequate:

• Commercial contracts and purchase orders
• Employment agreements and HR documents
• Non-disclosure agreements
• Internal approvals and sign-offs
• Patient consent forms (with appropriate HIPAA controls)
• FDA-regulated documents (with Part 11 compliant controls)

When Digital Signatures Are Necessary

Digital signatures become the right choice when cryptographic proof of authenticity is required or advantageous:

• EU Qualified Electronic Signatures (QES): When full legal equivalence to a handwritten signature is needed across EU member states.
• Government submissions: Certain regulatory bodies require digitally signed submissions (e.g., some electronic Common Technical Document, or eCTD, submissions).
• Long-term document verification: When documents must be independently verifiable years or decades after signing, without reliance on the original signing platform.
• High-value transactions: Mergers, acquisitions, or international treaties where the highest level of non-repudiation is required.
• Software distribution: Code signing to verify the authenticity and integrity of software packages.

Security Levels Compared

Neither type is inherently "more secure" than the other. Security depends on the full implementation. But they offer different security properties:

Electronic Signature Security

The security of an electronic signature depends entirely on the platform's controls. A well-built e-signature platform provides:

• Multi-factor authentication before signing
• Encrypted document storage (AES-256) and transmission (TLS 1.2+)
• Cryptographic hash chains in the audit trail
• RFC 3161 trusted timestamps from independent authorities
• Role-based access controls
• Tamper-evident document sealing

Platforms built for regulated industries, like Certivo, implement all of these controls to meet FDA 21 CFR Part 11 and HIPAA requirements. The resulting security posture can match or even exceed that of a basic digital signature.

Digital Signature Security

Digital signatures derive their security from the mathematical properties of asymmetric cryptography. Their strengths include:

• Cryptographic proof of signer identity (bound to a certificate)
• Built-in tamper detection at the document level
• Independent verifiability without platform access
• Non-repudiation through private key exclusivity

But digital signature security has its own vulnerabilities. If a signer's private key is compromised, an attacker can forge signatures. Certificate management (issuance, renewal, revocation) adds operational complexity. And the entire system's security hinges on the trustworthiness of the Certificate Authority.

What Regulated Industries Should Know

For organizations in life sciences, healthcare, and other regulated sectors, the choice between electronic and digital signatures comes down to specific regulatory requirements.

FDA-Regulated Industries (Pharma, Biotech, Medical Devices)

21 CFR Part 11 applies to electronic records and electronic signatures used in FDA-regulated activities. The regulation requires:

• Unique user identification (username/password or biometric)
• At least two distinct identification components for non-biometric signatures
• Complete audit trails of record creation, modification, and deletion
• System validation and operational controls
• Authority checks to ensure signers have appropriate permissions

Part 11 does not require PKI-based digital signatures. Organizations can achieve full compliance using electronic signatures with the right controls. Most life sciences companies take this approach because it balances compliance with usability. For guidance on GxP compliance across different practice areas, see our dedicated guide.

Healthcare (HIPAA)

HIPAA doesn't specify the type of signature required for documents involving protected health information. It focuses on the security controls surrounding the signing process: encryption, access controls, audit logging, and Business Associate Agreements. A well-implemented electronic signature platform meets these requirements without PKI infrastructure. Learn more in our guide on HIPAA-compliant electronic signatures.

Clinical Trials

Clinical trial documentation must meet ICH E6(R2) Good Clinical Practice requirements along with applicable national regulations. While some regulatory submissions may require digital signatures, the majority of clinical trial documents (informed consent forms, case report forms, monitoring reports) are effectively signed using electronic signatures with compliant controls.

What Are Common Misconceptions About Digital vs Electronic Signatures?

Several persistent myths cloud this discussion:

• "Digital signatures are more legally valid." In the United States, there is no legal distinction. Both are equally valid under the ESIGN Act. In the EU, only QES (which requires a digital signature) has automatic handwritten equivalence, but SES and AES are still legally admissible.
• "FDA requires digital signatures." Incorrect. FDA 21 CFR Part 11 requires electronic signatures with specific controls. It doesn't mandate PKI or certificates.
• "Electronic signatures aren't secure." Security depends on implementation. An electronic signature platform with MFA, encryption, hash chains, and RFC 3161 timestamps can be extremely secure.
• "You need both." Most organizations need one or the other, not both. The decision depends on your regulatory requirements, geographic scope, and document types. For most regulated U.S. companies, compliant electronic signatures are the practical choice.
• "A scanned handwritten signature is a digital signature." It isn't. A scanned image of a handwritten signature is a simple electronic signature with very low assurance. It has no cryptographic properties whatsoever.

Making the Right Choice for Your Organization

Start with your regulatory requirements and work backward:

1. Identify applicable regulations: Which rules govern your documents? (FDA Part 11, HIPAA, eIDAS, GxP, SOX, etc.)
2. Determine the required assurance level: Do your regulations require PKI-based signatures, or are properly controlled electronic signatures sufficient?
3. Assess your signing volume and signers: Digital signatures require certificate provisioning for each signer, which adds friction and cost at scale. Electronic signatures are generally simpler to deploy.
4. Consider long-term verification needs: If documents must be verifiable independently for decades, digital signatures offer an advantage. If your platform maintains audit records, electronic signatures are typically sufficient.
5. Evaluate total cost of ownership: Factor in certificate issuance, renewal, revocation management, hardware tokens (if needed), and user training alongside platform licensing.

For most life sciences and healthcare organizations, Certivo provides the practical path forward: electronic signatures with the compliance controls and security infrastructure that regulators require, without the overhead of managing a full PKI environment. The platform meets FDA 21 CFR Part 11 requirements out of the box, including two-factor authentication, tamper-evident audit trails, signature meaning declarations, and trusted timestamps.

The most important factor is choosing a platform that meets your specific regulatory obligations and gives auditors the evidence trail they expect. Explore our pricing to get started, or read our buyer's guide for life sciences e-signature platforms for a full evaluation framework.